These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8550782)

  • 21. Expression of the androgen receptor and 5 alpha-reductase type 2 in the developing human fetal penis and urethra.
    Kim KS; Liu W; Cunha GR; Russell DW; Huang H; Shapiro E; Baskin LS
    Cell Tissue Res; 2002 Feb; 307(2):145-53. PubMed ID: 11845321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunohistochemistry of the prostate and prostate carcinomas].
    Wernert N
    Veroff Pathol; 1991; 135():1-163. PubMed ID: 2038892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen receptor expression and 5 alpha-reductase activity along the proximal-distal axis of the rat prostatic duct.
    Prins GS; Cooke PS; Birch L; Donjacour AA; Yalcinkaya TM; Siiteri PK; Cunha GR
    Endocrinology; 1992 May; 130(5):3066-73. PubMed ID: 1572313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological and molecular evidence for the expression of the two steroid 5 alpha-reductase isozymes in normal and hyperplastic human prostatic cells in culture.
    Berthaut I; Mestayer C; Portois MC; Cussenot O; Mowszowicz I
    Prostate; 1997 Aug; 32(3):155-63. PubMed ID: 9254894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The localisation and expression of 5 alpha-reductase types I and II mRNAs in human hyperplastic prostate and in prostate primary cultures.
    Habib FK; Ross M; Bayne CW; Grigor K; Buck AC; Bollina P; Chapman K
    J Endocrinol; 1998 Mar; 156(3):509-17. PubMed ID: 9582508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunocytochemical localization of human 5 alpha-reductase 2 with polyclonal antibodies in androgen target and non-target human tissues.
    Eicheler W; Tuohimaa P; Vilja P; Adermann K; Forssmann WG; Aumüller G
    J Histochem Cytochem; 1994 May; 42(5):667-75. PubMed ID: 8157936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
    Gao J; Arnold JT; Isaacs JT
    Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical localization of the androgen receptor in rat and human tissues.
    Sar M; Lubahn DB; French FS; Wilson EM
    Endocrinology; 1990 Dec; 127(6):3180-6. PubMed ID: 1701137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of androgen receptor associated protein 55 (ARA55) in the developing human fetal prostate.
    Cai G; Huang H; Shapiro E; Zhou H; Yeh S; Melamed J; Greco MA; Lee P
    J Urol; 2005 Jun; 173(6):2190-3. PubMed ID: 15879885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stromal cells of the human prostate: initial isolation and characterization.
    Kassen A; Sutkowski DM; Ahn H; Sensibar JA; Kozlowski JM; Lee C
    Prostate; 1996 Feb; 28(2):89-97. PubMed ID: 8604397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxytocin increases 5alpha-reductase activity of human prostate epithelial cells, but not stromal cells.
    Assinder SJ
    Prostate; 2008 Feb; 68(2):115-21. PubMed ID: 18008328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistolocalization of the carbonic anhydrase isoenzymes (CA-I, CA-II, and CA-III) in the reproductive tract of male horses.
    Asari M; Sasaki K; Miura K; Ichihara N; Nishita T
    Am J Vet Res; 1996 Apr; 57(4):439-43. PubMed ID: 8712504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of 5 alpha-reductase in bacteria as a trp E fusion protein and its use in the production of antibodies for immunocytochemical localization of 5 alpha-reductase.
    Hiipakka RA; Wang M; Bloss T; Ito K; Liao S
    J Steroid Biochem Mol Biol; 1993 Jun; 45(6):539-48. PubMed ID: 8518208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
    Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen and prostatic stroma.
    Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
    Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-type-specific expression of rat steroid 5 alpha-reductase isozymes.
    Berman DM; Russell DW
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9359-63. PubMed ID: 8415707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmental and hormonal regulation of transforming growth factor-alpha and epidermal growth factor receptor gene expression in isolated prostatic epithelial and stromal cells.
    Itoh N; Patel U; Skinner MK
    Endocrinology; 1998 Mar; 139(3):1369-77. PubMed ID: 9492074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunocytochemical localization of 4-ene steroid 5 alpha-reductase type 1 along the rat epididymis during postnatal development.
    Viger RS; Robaire B
    Endocrinology; 1994 May; 134(5):2298-306. PubMed ID: 8156933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localization of estrogen and androgen receptors in male reproductive tissues of mice and rats.
    Yamashita S
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Aug; 279(2):768-78. PubMed ID: 15278948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Messenger RNA levels and enzyme activities of 5 alpha-reductase types 1 and 2 in human benign prostatic hyperplasia (BPH) tissue.
    Shirakawa T; Okada H; Acharya B; Zhang Z; Hinata N; Wada Y; Uji T; Kamidono S; Gotoh A
    Prostate; 2004 Jan; 58(1):33-40. PubMed ID: 14673950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.